Assessing  ||| S:0 E:10 ||| VBG
sleep  ||| S:10 E:16 ||| NN
in  ||| S:16 E:19 ||| IN
fibromyalgia ||| S:19 E:31 ||| NNS
:  ||| S:31 E:33 ||| :
investigation  ||| S:33 E:47 ||| NN
of  ||| S:47 E:50 ||| IN
an  ||| S:50 E:53 ||| DT
alternative  ||| S:53 E:65 ||| JJ
scoring  ||| S:65 E:73 ||| JJ
method  ||| S:73 E:80 ||| NN
for  ||| S:80 E:84 ||| IN
the  ||| S:84 E:88 ||| DT
Jenkins  ||| S:88 E:96 ||| NNP
Sleep  ||| S:96 E:102 ||| NNP
Scale  ||| S:102 E:108 ||| NNP
based  ||| S:108 E:114 ||| VBN
on  ||| S:114 E:117 ||| IN
data  ||| S:117 E:122 ||| NNS
from  ||| S:122 E:127 ||| IN
randomized  ||| S:127 E:138 ||| JJ
controlled  ||| S:138 E:149 ||| JJ
studies  ||| S:149 E:157 ||| NNS
To  ||| S:157 E:160 ||| TO
investigate  ||| S:160 E:172 ||| VB
the  ||| S:172 E:176 ||| DT
validity  ||| S:176 E:185 ||| NN
of  ||| S:185 E:188 ||| IN
a  ||| S:188 E:190 ||| DT
rescored  ||| S:190 E:199 ||| JJ
version  ||| S:199 E:207 ||| NN
of  ||| S:207 E:210 ||| IN
the  ||| S:210 E:214 ||| DT
Jenkins  ||| S:214 E:222 ||| NNP
Sleep  ||| S:222 E:228 ||| NNP
Scale  ||| S:228 E:234 ||| NNP
( ||| S:234 E:235 ||| -LRB-
JSS ||| S:235 E:238 ||| NNP
)  ||| S:238 E:240 ||| -RRB-
to  ||| S:240 E:243 ||| TO
assess  ||| S:243 E:250 ||| VB
the  ||| S:250 E:254 ||| DT
extent  ||| S:254 E:261 ||| NN
of  ||| S:261 E:264 ||| IN
possible  ||| S:264 E:273 ||| JJ
bias  ||| S:273 E:278 ||| NN
of  ||| S:278 E:281 ||| IN
a  ||| S:281 E:283 ||| DT
4-week  ||| S:283 E:290 ||| JJ
recall  ||| S:290 E:297 ||| NN
period  ||| S:297 E:304 ||| NN
in  ||| S:304 E:307 ||| IN
assessing  ||| S:307 E:317 ||| VBG
sleep  ||| S:317 E:323 ||| NN
in  ||| S:323 E:326 ||| IN
patients  ||| S:326 E:335 ||| NNS
with  ||| S:335 E:340 ||| IN
fibromyalgia ||| S:340 E:352 ||| NN
.  ||| S:352 E:354 ||| .
A  ||| S:354 E:356 ||| DT
rescoring  ||| S:356 E:366 ||| JJ
algorithm  ||| S:366 E:376 ||| NN
of  ||| S:376 E:379 ||| IN
the  ||| S:379 E:383 ||| DT
JSS  ||| S:383 E:387 ||| NNP
was  ||| S:387 E:391 ||| VBD
developed ||| S:391 E:400 ||| VBN
.  ||| S:400 E:402 ||| .
The  ||| S:402 E:406 ||| DT
psychometric  ||| S:406 E:419 ||| JJ
properties  ||| S:419 E:430 ||| NNS
of  ||| S:430 E:433 ||| IN
the  ||| S:433 E:437 ||| DT
rescored  ||| S:437 E:446 ||| JJ
JSS  ||| S:446 E:450 ||| NNP
were  ||| S:450 E:455 ||| VBD
examined  ||| S:455 E:464 ||| VBN
using  ||| S:464 E:470 ||| VBG
blinded ||| S:470 E:477 ||| NN
,  ||| S:477 E:479 ||| ,
observed  ||| S:479 E:488 ||| VBD
data  ||| S:488 E:493 ||| NNS
from  ||| S:493 E:498 ||| IN
a  ||| S:498 E:500 ||| DT
Phase  ||| S:500 E:506 ||| NNP
2  ||| S:506 E:508 ||| CD
trial  ||| S:508 E:514 ||| NN
( ||| S:514 E:515 ||| -LRB-
n=195 ||| S:515 E:520 ||| NNP
)  ||| S:520 E:522 ||| -RRB-
in  ||| S:522 E:525 ||| IN
subjects  ||| S:525 E:534 ||| NNS
with  ||| S:534 E:539 ||| IN
fibromyalgia ||| S:539 E:551 ||| NN
.  ||| S:551 E:553 ||| .
In  ||| S:553 E:556 ||| IN
addition ||| S:556 E:564 ||| NN
,  ||| S:564 E:566 ||| ,
data  ||| S:566 E:571 ||| NNS
from  ||| S:571 E:576 ||| IN
two  ||| S:576 E:580 ||| CD
Phase  ||| S:580 E:586 ||| NN
3 ||| S:586 E:587 ||| CD
,  ||| S:587 E:589 ||| ,
randomised ||| S:589 E:599 ||| NN
,  ||| S:599 E:601 ||| ,
controlled  ||| S:601 E:612 ||| VBN
trials  ||| S:612 E:619 ||| NNS
( ||| S:619 E:620 ||| -LRB-
n=1,121 ||| S:620 E:627 ||| NNP
)  ||| S:627 E:629 ||| -RRB-
in  ||| S:629 E:632 ||| IN
subjects  ||| S:632 E:641 ||| NNS
with  ||| S:641 E:646 ||| IN
fibromyalgia  ||| S:646 E:659 ||| NN
were  ||| S:659 E:664 ||| VBD
used  ||| S:664 E:669 ||| VBN
to  ||| S:669 E:672 ||| TO
further  ||| S:672 E:680 ||| VB
validate  ||| S:680 E:689 ||| VBN
the  ||| S:689 E:693 ||| DT
rescored  ||| S:693 E:702 ||| JJ
JSS  ||| S:702 E:706 ||| NN
by  ||| S:706 E:709 ||| IN
conducting  ||| S:709 E:720 ||| VBG
correlation  ||| S:720 E:732 ||| JJ
analyses  ||| S:732 E:741 ||| NNS
with  ||| S:741 E:746 ||| IN
other  ||| S:746 E:752 ||| JJ
assessments  ||| S:752 E:764 ||| NNS
expected  ||| S:764 E:773 ||| VBN
to  ||| S:773 E:776 ||| TO
correlate  ||| S:776 E:786 ||| VB
with  ||| S:786 E:791 ||| IN
sleep ||| S:791 E:796 ||| NN
.  ||| S:796 E:798 ||| .
These  ||| S:798 E:804 ||| DT
included  ||| S:804 E:813 ||| JJ
fatigue  ||| S:813 E:821 ||| NN
and  ||| S:821 E:825 ||| CC
tiredness  ||| S:825 E:835 ||| JJ
items  ||| S:835 E:841 ||| NNS
from  ||| S:841 E:846 ||| IN
the  ||| S:846 E:850 ||| DT
Fibromyalgia  ||| S:850 E:863 ||| NNP
Impact  ||| S:863 E:870 ||| NNP
Questionnaire  ||| S:870 E:884 ||| NNP
( ||| S:884 E:885 ||| -LRB-
FIQ ||| S:885 E:888 ||| NNP
) ||| S:888 E:889 ||| -RRB-
,  ||| S:889 E:891 ||| ,
the  ||| S:891 E:895 ||| DT
Functional  ||| S:895 E:906 ||| NNP
Outcomes  ||| S:906 E:915 ||| NNP
of  ||| S:915 E:918 ||| IN
Sleep  ||| S:918 E:924 ||| NNP
Questionnaire  ||| S:924 E:938 ||| NNP
( ||| S:938 E:939 ||| -LRB-
FOSQ ||| S:939 E:943 ||| NNP
) ||| S:943 E:944 ||| -RRB-
,  ||| S:944 E:946 ||| ,
and  ||| S:946 E:950 ||| CC
the  ||| S:950 E:954 ||| DT
Short  ||| S:954 E:960 ||| NNP
Form-36  ||| S:960 E:968 ||| NNP
( ||| S:968 E:969 ||| -LRB-
SF-36™ ||| S:969 E:975 ||| NNP
)  ||| S:975 E:977 ||| -RRB-
Vitality  ||| S:977 E:986 ||| NNP
scale ||| S:986 E:991 ||| NN
.  ||| S:991 E:993 ||| .
Construct  ||| S:993 E:1003 ||| JJ
validity  ||| S:1003 E:1012 ||| NN
of  ||| S:1012 E:1015 ||| IN
the  ||| S:1015 E:1019 ||| DT
rescored  ||| S:1019 E:1028 ||| JJ
JSS  ||| S:1028 E:1032 ||| NNP
was  ||| S:1032 E:1036 ||| VBD
found  ||| S:1036 E:1042 ||| VBN
to  ||| S:1042 E:1045 ||| TO
be  ||| S:1045 E:1048 ||| VB
acceptable ||| S:1048 E:1058 ||| JJ
,  ||| S:1058 E:1060 ||| ,
with  ||| S:1060 E:1065 ||| IN
an  ||| S:1065 E:1068 ||| DT
internal  ||| S:1068 E:1077 ||| JJ
consistency  ||| S:1077 E:1089 ||| JJ
reliability  ||| S:1089 E:1101 ||| NN
of  ||| S:1101 E:1104 ||| IN
α=0.70 ||| S:1104 E:1110 ||| CD
.  ||| S:1110 E:1112 ||| .
Test-retest  ||| S:1112 E:1124 ||| JJ
reliability  ||| S:1124 E:1136 ||| NN
on  ||| S:1136 E:1139 ||| IN
stable  ||| S:1139 E:1146 ||| JJ
subjects ||| S:1146 E:1154 ||| NNS
,  ||| S:1154 E:1156 ||| ,
defined  ||| S:1156 E:1164 ||| VBN
using  ||| S:1164 E:1170 ||| VBG
the  ||| S:1170 E:1174 ||| DT
FIQ  ||| S:1174 E:1178 ||| NNP
total  ||| S:1178 E:1184 ||| JJ
score ||| S:1184 E:1189 ||| NN
,  ||| S:1189 E:1191 ||| ,
was  ||| S:1191 E:1195 ||| VBD
also  ||| S:1195 E:1200 ||| RB
acceptable  ||| S:1200 E:1211 ||| JJ
( ||| S:1211 E:1212 ||| -LRB-
ICC=0.70 ||| S:1212 E:1220 ||| NNP
) ||| S:1220 E:1221 ||| -RRB-
.  ||| S:1221 E:1223 ||| .
Moderate  ||| S:1223 E:1232 ||| JJ
to  ||| S:1232 E:1235 ||| TO
high  ||| S:1235 E:1240 ||| JJ
correlations  ||| S:1240 E:1253 ||| NNS
( ||| S:1253 E:1254 ||| -LRB-
Pearson  ||| S:1254 E:1262 ||| NNP
r ||| S:1262 E:1263 ||| SYM
> ||| S:1263 E:1264 ||| CD
0.66 ||| S:1264 E:1268 ||| CD
)  ||| S:1268 E:1270 ||| -RRB-
were  ||| S:1270 E:1275 ||| VBD
found  ||| S:1275 E:1281 ||| VBN
with  ||| S:1281 E:1286 ||| IN
two  ||| S:1286 E:1290 ||| CD
FIQ  ||| S:1290 E:1294 ||| NN
items ||| S:1294 E:1299 ||| NNS
,  ||| S:1299 E:1301 ||| ,
addressing  ||| S:1301 E:1312 ||| VBG
fatigue  ||| S:1312 E:1320 ||| NNS
and  ||| S:1320 E:1324 ||| CC
non-restorative  ||| S:1324 E:1340 ||| JJ
sleep ||| S:1340 E:1345 ||| NN
,  ||| S:1345 E:1347 ||| ,
and  ||| S:1347 E:1351 ||| CC
the  ||| S:1351 E:1355 ||| DT
SF-36™  ||| S:1355 E:1362 ||| NNP
Vitality  ||| S:1362 E:1371 ||| NNP
scale ||| S:1371 E:1376 ||| NN
;  ||| S:1376 E:1378 ||| :
correlations  ||| S:1378 E:1391 ||| NN
with  ||| S:1391 E:1396 ||| IN
the  ||| S:1396 E:1400 ||| DT
original  ||| S:1400 E:1409 ||| JJ
JSS  ||| S:1409 E:1413 ||| NNP
were  ||| S:1413 E:1418 ||| VBD
similar ||| S:1418 E:1425 ||| JJ
.  ||| S:1425 E:1427 ||| .
Both  ||| S:1427 E:1432 ||| DT
JSS  ||| S:1432 E:1436 ||| NNP
versions  ||| S:1436 E:1445 ||| NNS
were  ||| S:1445 E:1450 ||| VBD
found  ||| S:1450 E:1456 ||| VBN
to  ||| S:1456 E:1459 ||| TO
be  ||| S:1459 E:1462 ||| VB
responsive  ||| S:1462 E:1473 ||| JJ
( ||| S:1473 E:1474 ||| -LRB-
p  ||| S:1474 E:1475 ||| FW
< ||| S:1475 E:1476 ||| SYM
0.0001 ||| S:1476 E:1482 ||| FW
) ||| S:1482 E:1483 ||| -RRB-
,  ||| S:1483 E:1485 ||| ,
and  ||| S:1485 E:1489 ||| CC
the  ||| S:1489 E:1493 ||| DT
rescored  ||| S:1493 E:1502 ||| JJ
version  ||| S:1502 E:1510 ||| NN
accounted  ||| S:1510 E:1520 ||| VBD
for  ||| S:1520 E:1524 ||| IN
90 ||| S:1524 E:1526 ||| CD
%  ||| S:1526 E:1528 ||| NN
of  ||| S:1528 E:1531 ||| IN
the  ||| S:1531 E:1535 ||| DT
variance  ||| S:1535 E:1544 ||| NN
captured  ||| S:1544 E:1553 ||| VBN
in  ||| S:1553 E:1556 ||| IN
the  ||| S:1556 E:1560 ||| DT
original  ||| S:1560 E:1569 ||| JJ
version ||| S:1569 E:1576 ||| NN
.  ||| S:1576 E:1578 ||| .
These  ||| S:1578 E:1584 ||| DT
results  ||| S:1584 E:1592 ||| NNS
showed  ||| S:1592 E:1599 ||| VBD
the  ||| S:1599 E:1603 ||| DT
rescored  ||| S:1603 E:1612 ||| JJ
JSS  ||| S:1612 E:1616 ||| NNP
performed  ||| S:1616 E:1626 ||| VBD
similarly  ||| S:1626 E:1636 ||| RB
to  ||| S:1636 E:1639 ||| TO
the  ||| S:1639 E:1643 ||| DT
original  ||| S:1643 E:1652 ||| JJ
scale ||| S:1652 E:1657 ||| NN
,  ||| S:1657 E:1659 ||| ,
suggesting  ||| S:1659 E:1670 ||| VBG
the  ||| S:1670 E:1674 ||| DT
original  ||| S:1674 E:1683 ||| JJ
scale ||| S:1683 E:1688 ||| NN
's  ||| S:1688 E:1691 ||| POS
4-week  ||| S:1691 E:1698 ||| JJ
recall  ||| S:1698 E:1705 ||| NN
period  ||| S:1705 E:1712 ||| NN
did  ||| S:1712 E:1716 ||| VBD
not  ||| S:1716 E:1720 ||| RB
introduce  ||| S:1720 E:1730 ||| VB
substantial  ||| S:1730 E:1742 ||| JJ
bias  ||| S:1742 E:1747 ||| NN
in  ||| S:1747 E:1750 ||| IN
capturing  ||| S:1750 E:1760 ||| VBG
the  ||| S:1760 E:1764 ||| DT
experience  ||| S:1764 E:1775 ||| NN
of  ||| S:1775 E:1778 ||| IN
fibromyalgia-related  ||| S:1778 E:1799 ||| JJ
sleep  ||| S:1799 E:1805 ||| NN
disturbances ||| S:1805 E:1817 ||| NNS
.  ||| S:1817 E:1819 ||| .
